Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Risk of HCC in Hepatitis B and D Virus Co-infected Patients Risk of HCC in Hepatitis B and D Virus Co-infected Patients
Does coinfection with hepatitis D virus further increase the risk of hepatocellular carcinoma in patients with hepatitis B infection?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 1, 2021 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
Medivir Appoints Jens Lindberg as Chief Executive Officer
STOCKHOLM, Oct. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Board of Directors has appointed Jens Lindberg as CEO of the company. Jens Lindberg has extensive experience from the pharma... Biopharmaceuticals, Personnel Medivir, hepatocellular carcinoma, liver cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 25, 2021 Category: Pharmaceuticals Source Type: news
Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres(R) Y-90 resin microspheres in China
WOBURN, Mass., Oct. 11, 2021 -- (Healthcare Sales & Marketing Network) -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that the first procedure of selective internal radiation therapy (SIR... Devices, Oncology Sirtex Medical, SIR-Spheres, Y-90 resin microspheres, hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 11, 2021 Category: Pharmaceuticals Source Type: news
Hepatocellular carcinoma screening in cirrhotic patients is worth it in Australia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news
Use Live Donors for Liver Transplants for HCC Patients Use Live Donors for Liver Transplants for HCC Patients
For patients with hepatocelluar carcinoma (HCC), liver transplant from a live donor improves survival and frees up organs from deceased donors for other patients on the long waiting list.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Wake Forest School of Medicine Research shows radio-wave therapy is safe for liver cancer patients and improves overall survival
Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer. The therapy also showed a benefit in overall survival.
The study findings appear online in 4Open, a journal published by EDP Sciences.
“HCC accounts for nearly 90% of all liver cancers, and current survival rates are between six and 20 months,” said Dr. Boris Pasche, chair of cancer… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 15, 2021 Category: American Health Authors: Atrium Health Wake Forest Baptist Source Type: news
Wake Forest School of Medicine Research shows radio-wave therapy is safe for liver cancer patients and improves overall survival
Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer. The therapy also showed a benefit in overall survival.
The study findings appear online in 4Open, a journal published by EDP Sciences.
“HCC accounts for nearly 90% of all liver cancers, and current survival rates are between six and 20 months,” said Dr. Boris Pasche, chair of cancer… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 15, 2021 Category: Biotechnology Authors: Atrium Health Wake Forest Baptist Source Type: news
Ramucirumab Shows Survival Benefits with Pleural Mesothelioma
Adding the drug ramucirumab to gemcitabine chemotherapy worked especially well in a recent clinical trial involving second-line treatment for patients with pleural mesothelioma.
Ramucirumab, an immunotherapy drug also known by the brand name Cyramza, is a monoclonal antibody that works by targeting and restricting a protein that stimulates blood vessel growth within tumors.
Impressive results in the phase II clinical trial moved the drug combination closer to filling the long-standing void for a second-line mesothelioma treatment.
The Lancet Oncology recently published results of the study, which was conducted in ...
Source: Asbestos and Mesothelioma News - September 13, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news
PET identifies early responders to liver cancer treatment
PET imaging can predict how liver cancer patients are going to respond earl...Read more on AuntMinnie.comRelated Reading:
AI can identify hepatocellular carcinoma on liver CT exams
FCH-PET shines in guiding parathyroid surgery
Study evaluates safety of new liver cancer treatment
Sirtex launches study to assess SIR-Spheres for HCC
US microbubble destruction may improve TARE response (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 10, 2021 Category: Radiology Source Type: news
Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients
Might nonselective beta-blockers such as carvedilol, nadolol, and propranolol decrease the risk of hepatocellular carcinoma among patients with cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 6, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Fraction of Cirrhosis and HCC Attributable to Hepatitis B and C Fraction of Cirrhosis and HCC Attributable to Hepatitis B and C
This study assessed a protocol developed by WHO to collect data on the worldwide fraction of cirrhosis and hepatocellular carcinoma attributable to hepatitis B and C. How might it be improved?Journal of Viral Hepatitis (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 6, 2021 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news
Effect of NSAIDs and APT on Incidence and Recurrence of HCC Effect of NSAIDs and APT on Incidence and Recurrence of HCC
This study investigated whether NSAIDs or aspirin might have an impact on hepatocellular carcinoma incidence or recurrence among high-risk persons with chronic liver disease.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
High Success Rates With Down-Staging of Liver Cancer Prior to Transplant High Success Rates With Down-Staging of Liver Cancer Prior to Transplant
Down-staging of hepatocellular carcinoma prior to liver transplant based on UNOS criteria is successful most of the time using either chemoembolization or Y-90 radioembolization, new research indicates.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 30, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
PET recommended over bone scintigraphy in pediatric sarcoma
PET imaging is more effective than bone scintigraphy for detecting metastati...Read more on AuntMinnie.comRelated Reading:
Body position on x-ray affects radiation dose in children
Deep learning classifies brain tumors on single MRI scans
AI can identify hepatocellular carcinoma on liver CT exams
Black women less likely to receive breast surgery follow-up
MRI offers kids radiation-free chemo response tracking (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 13, 2021 Category: Radiology Source Type: news
